Descemet's membrane endothelial keratoplasty rejection after SARS-COV2 infection or vaccination: 2-year retrospective study.

PURPOSE: To assess the incidence of Descemet's membrane endothelial keratoplasty (DMEK) rejection potentially associated with coronavirus disease 2019 (COVID-19) infection or vaccination, and its association with known rejection risk factors during the first two years of the pandemic. METHODS: This retrospective study included patients with DMEK rejection between January 2020 and December 2021. Diagnostic criteria were based on symptoms, visual acuity, and other clinical assessments. Risk factors for graft rejection were considered, and a telephone survey was conducted to identify possible preceding COVID-19 infection or vaccination. RESULTS: Of 58 patients, 44 were included. Six patients (14%) reported COVID-19 infection, with one immediate endothelial graft rejection (EGR) post-infection. After vaccine availability, 13 of 36 patients had EGR at an average of 2.7 months post-vaccination. Five (38%) had immediate EGR following vaccination, four of which had concomitant risk factors for rejection. CONCLUSION: Although the risk of endothelial graft rejection (EGR) associated with COVID-19 infection or vaccination appears to be extremely low, there may be a causative relationship, especially in patients with pre-existing risk factors for EGR. A temporary increase in anti-rejection treatment following COVID-19 infection or vaccination is recommended, especially in patients with pre-existing risk factors, along with closer monitoring during the subsequent 4 to 8 weeks.

Success of ChatGPT, an AI language model, in taking the French language version of the European Board of Ophthalmology examination: A novel approach to medical knowledge assessment.

PURPOSE: The purpose of this study was to evaluate the performance of ChatGPT, a cutting-edge artificial intelligence (AI) language model developed by OpenAI, in successfully completing the French language version of the European Board of Ophthalmology (EBO) examination and to assess its potential role in medical education and knowledge assessment. METHODS: ChatGPT, based on the GPT-4 architecture, was exposed to a series of EBO examination questions in French, covering various aspects of ophthalmology. The AI's performance was evaluated by comparing its responses with the correct answers provided by ophthalmology experts. Additionally, the study assessed the time taken by ChatGPT to answer each question as a measure of efficiency. RESULTS: ChatGPT achieved a 91% success rate on the EBO examination, demonstrating a high level of competency in ophthalmology knowledge and application. The AI provided correct answers across all question categories, indicating a strong understanding of basic sciences, clinical knowledge, and clinical management. The AI model also answered the questions rapidly, taking only a fraction of the time needed by human test-takers. CONCLUSION: ChatGPT's performance on the French language version of the EBO examination demonstrates its potential to be a valuable tool in medical education and knowledge assessment. Further research is needed to explore optimal ways to implement AI language models in medical education and to address the associated ethical and practical concerns.

Surgical approaches to autologous limbal stem cell transplantation (LSCT) following severe corneal chemical burns.

Chemical injury of the conjunctiva and cornea are true ocular emergencies and require immediate intervention. They can produce severe, extensive ocular damage, including limbal stem cell deficiency (LSCD), and lead to irreversible visual loss. LSCD can be treated surgically through autologous limbal stem cell transplantation (LSCT). Autologous LSCT can be performed through cultivated limbal epithelial transplantation (CLET) or by direct grafting of limbal epithelial cells through conjunctival-limbal autografting (CLAU) or simple limbal epithelial transplantation (SLET). In this review we provide an overview of each surgical approach. CLET allows for a implantation of a large graft in the recipient eye while preserving donor cells. Its success rate is higher with an increased number of transplanted stem cells; failures tend to occur within the first year. CLAU is performed by directly transplanting autologous limbal stem cells from the patient's healthy eye, reducing the risk of immune rejection. This constitutes a risk for the donor eye, as the removal of stem cells from the fellow eye may lead to LSCD in the donor eye. SLET consists of direct implantation of donor stem cells on an amniotic membrane, thus avoiding the need for ex-vivo expansion. Combinations of CLAU and SLET within a single procedure have also been successfully utilized. Autologous LCST is an effective technique for surgical management of unilateral LCSD. Depending on the patient history and status of the fellow eye, either CLET, CLAU or SLET (including the combination of mini-CLAU and SLET) can be used to restore long-term function and prevent visual impairment.

Non stripping descemet membrane endothelial keratoplasty in difficult cases: A case series.

Endothelial keratoplasty (EK) has been increasingly used instead of penetrating keratoplasty (PK) in the management of post PK graft rejection. Both DSAEK and DMEK involve the surgical removal of the diseased host endothelial cell layer and Descemet's membrane (DM) (descemetorhexis) before transplantation, a technically challenging step, especially in post-PK eyes. Understandably, interest arose when non-stripping DMEK (nDMEK) was described in 2013, and recent studies suggested encouraging results without increased early postoperative failures or complications requiring rebubbling. The purpose of our series was to further study the feasibility and safety of nDMEK and to compare the results with traditional DMEK. This is a single center case series of 3 eyes which underwent nDMEK performed by experienced surgeons (C.P, A.M). Two eyes had nDMEK as a secondary procedure following a failed/rejected PK, while the third case underwent nDMEK on a virgin eye. Undiseased donor DM and a regular host endothelium were required to be eligible for nDMEK. The average change in CCT at last follow-up was -21.2% (±13.3). All required intracameral air injection (rebubbling) within the first few days, with a mean of 2.33 rebubblings per eye, the first one occurring at 6.33±2.52 days after surgery. Non-stripping DMEK surgery appears to be a feasible option, and results are satisfactory at mid to long term. However, in our series, the immediate postoperative period was marked by an increased rebubbling rate. While foreseeable particularly in high-risk cases, surgeons considering this technique should expect a higher risk of early rejection.

Myopic outcomes after excimer laser phototherapeutic keratectomy (PTK).

PURPOSE: To evaluate refractive outcomes following excimer laser phototherapeutic keratectomy (PTK). METHODS: A retrospective non-randomized review of refractive outcomes of 146 consecutive eyes treated with excimer laser PTK at the Rothschild Foundation, Paris, France. Inclusion criteria were all patients undergoing PTK laser using a flying spot excimer laser system (Wavelight Allegretto, Alcon Surgical, Inc.) from October 2016 to June 2018. Exclusion criteria were incomplete data, irregular astigmatism and dystrophies of uncertain diagnosis. Preoperative diagnoses included recurrent corneal erosion syndrome without dystrophy and Cogan corneal dystrophies. The primary outcome measure was the change in spherical equivalent (SEQ) at M1 post PTK. The secondary outcome measure was the creation of a regression equation for predicting refractive outcomes after PTK, by analyzing the effect of ablation depth (AD) and optical zone (OZ) diameter. RESULTS: Fifty-eight eyes of 54 patients were included. The mean OZ was 7.352 mm±0.622. The mean AD was 18.362µm±21.406. At M1 postoperatively, the mean SEQ was -2.485 D±2.628 and mean final SEQ was -1.052 D±1.260. Both OZ and AD were independent variables with significant effects on the final visual outcome. A regression equation for predicting refractive outcomes was established. No complications were observed. CONCLUSION: The Wavelight flying spot excimer laser system produces myopic outcomes following PTK. Both OZ and AD are significant variables. A regression equation was created and may aid in prediction of refractive outcomes following PTK.